RESP — Respiratorius AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK19.44m
- SEK19.44m
- SEK0.03m
Brief: The russian patent office allows patent for RESP3000
Brief: Respiratorius: Japan Patent Office allows patent for RESP3000
Brief: Respiratorius: FDA grants Orphan Drug Designation for VAL001
Brief: Respiratorius: US Patent Office allows further Patent for RESP3000
Brief: Respiratorius: Australian Patent Office approves patent for RESP 3000
Brief: Respiratorius gets Orphan Drug Designation for VAL001 in EU
Brief: Respiratorius: European Patent Office grants patents for VAL001
Brief: Respiratorius: EMA recommends European Orphan Drug Designation for VAL001
Brief: Respiratorius: Japan first country to approve VAL001 patent